ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Hear
about
Ventricular pacing - Electromechanical consequences and valvular functionEvolution from electrophysiologic to hemodynamic monitoring: the story of left atrial and pulmonary artery pressure monitorsCritical analysis of ineffective post implantation implantable cardioverter-defibrillator-testingEchocardiography and cardiac resynchronisation therapy, friends or foes?Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.The clinical challenge of preventing sudden cardiac death immediately after acute ST-elevation myocardial infarction.Predictors of serious arrhythmic events in patients with nonischemic heart failure.Stratification of the risk of sudden death in nonischemic heart failure.Tools for risk stratification of sudden cardiac death: a review of the literature in different patient populationsCardiovascular Computed Tomography and Magnetic Resonance: History and Growing Impact in Brazil and in the WorldClinician's guide to the updated ABCs of cardiovascular disease prevention.Editorial Comment: Over, Under, or Just Right? How do we interpret ICD utilization in the modern era?A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design.Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.International survey of knowledge, attitudes, and practices of cardiologists regarding prevention and management of cardiac implantable electronic device infections.Bridging the gap between heart failure and the device clinic.Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.Applications of Advanced Imaging in Cardiac Electrophysiology.Integration of new technology into clinical practice after FDA approval.Cardiovascular complications in chronic dialysis patients.Pre-Implant Assessment For Optimal LV Lead Placement In CRT: ECG, ECHO, or MRI?Technologies for Prolonging Cardiac Implantable Electronic Device Longevity.Outcomes of lead extraction without subsequent device reimplantation.Rapid and Potent Antiarrhythmic Effect of Cardiac Resynchronization Therapy in a Patient with Advanced Dilated Cardiomyopathy and a Large Ventricular Arrhythmia Burden.Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death.Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-stuThe electromechanical substrate for response to cardiac resynchronization therapy in patients with right bundle branch block.Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies.Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity.To downgrade, or not to downgrade: that is the question.Up-to-date cardiac resynchronization therapy.Incidence of ineffective safety margin testing (<10 J) and efficacy of routine subcutaneous array insertion during implantable cardioverter defibrillator implantation.Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
P2860
Q26739896-8D79A7CD-DF4B-44B7-A244-1F2C5C097F87Q26779274-71B6F740-B1AA-4760-B1E8-2085FF2BB949Q30313343-F668746A-D70F-4555-84CB-682713FFB539Q30394543-352560EE-3FA4-4218-8F1B-A43C44D4FDA7Q30755342-6F421126-8CA0-4833-BBEC-17B9CA361C9DQ30891180-796178B6-EFBA-48C7-86AE-2C3F257E2033Q30953069-EAC03EE8-644D-498F-AFD1-274F582BB788Q33164931-95D69509-9041-4D20-A95C-69E98DEE8575Q33167997-0C28F58D-C954-42A6-9504-F51C72FE3A6AQ34387880-7C55FFF6-FDBB-4D66-BCC4-1421AE4A6A6FQ34541818-7283FAD7-2E94-49B1-B21E-59B0A4F169E4Q34669951-951A0FA6-1F9A-4468-92C1-C52DBBC3CFE1Q35070830-CE7F6311-E863-450C-B72D-C91C01935D63Q35235970-C434A679-5EBF-4DB0-8AAE-DA1712FDA069Q35335708-8A13E3A0-DD3C-4382-AB73-C90D61F83D6EQ35587006-6717119C-D17A-41B6-93CE-5F1B8AAB1D2BQ36236154-44D7C4AD-FFB1-4492-B704-AA6DEA6F9D3FQ38397913-59087939-49CD-4470-BA4B-E939AEF45EF7Q38605893-F65E7E09-DD72-4798-AEB5-D906690F8329Q38682924-66F01961-BEE3-4A21-972B-70A2D08F97D0Q38724112-C4009A29-18AF-401C-AA09-8C8290A4D246Q38819674-4B06BDA0-E61A-405F-A672-F29DB7103AEDQ38938300-6184DDDC-BD5B-4C16-B1DD-4F4A38C460BDQ38956399-33D984BB-3A60-403F-8929-5D650CF98FAFQ38970075-8FA497F0-138B-4271-9FFA-61225DD1C56FQ39036267-1C5819B2-F25F-47F7-A32B-B2B3F053C36BQ40515780-F2EC50D7-791E-4F7E-909D-8C4626B49721Q41190923-DD6F74EA-76FF-4788-B839-AB51504FD15CQ45073081-650AA859-582A-425B-ADCB-F1F47F501D17Q46160078-7130F4C3-483E-4966-81E7-586BD0610B33Q47203009-3F8FAFEE-734F-4E8E-885A-1AAE8CC9060DQ47786609-B44B90DC-6994-43D5-89A9-54057DD1D293Q48096932-760AFD81-60BA-4D52-BCA9-51F7E3DBB743Q49819919-C75A121F-1B21-46A2-B530-A30D5FD5D00CQ50016512-AFBA1CFB-781D-4193-A6B2-86A40F461544Q50089177-C8CA59EC-FF63-4402-A4D1-405E48B59E2AQ52741625-F9B1AB5A-9B89-45FF-8579-D7A93B62B341Q55074102-36714B2D-AC42-4FA6-91F6-E12DFA29E428Q55425790-9943DDB4-85BE-45BC-B38A-7C951E479059Q57626635-C490F600-A7A8-4E8B-9AFE-7529FA2F79E4
P2860
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Hear
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@en
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@nl
type
label
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@en
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@nl
prefLabel
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@en
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@nl
P2093
P50
P1433
P1476
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCC ...... use criteria task force, Hear
@en
P2093
Andrea M Russo
Andrew E Epstein
Bruce D Lindsay
Lynne Warner Stevenson
Mark S Kremers
Steven R Bailey
Suraj Kapa
P304
P356
10.1016/J.HRTHM.2013.01.008
P577
2013-03-07T00:00:00Z